Clinical and Anti-inflammatory Effect of Curcumin Oral Gel as Adjuncts in Treatment of Periodontal Pocket
Launched by UNIVERSITY OF BAGHDAD · Apr 20, 2020
Trial Information
Current as of April 25, 2025
Unknown status
Keywords
ClinConnect Summary
Abstract:
Background: Complete removal of irritants is not possible with mechanical therapy alone. Adjunctive use of systemic administration of antibiotics results in the distribution of drug throughout the body, which can give rise to toxicity. Curcumin (diferuloylmethane), a constituent of Curcuma longa plant, which possess antioxidant, anti-inflammatory, and anti-microbial properties. The aim of the study is to determine the effect of curcumin oral gel on the anti-inflammatory chemokines (IL_8) in the gingival crevicular fluid and to compare the effects of the curcumin gel as an adjunct...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Age group of 30-45 years.
- • 2. Belonging to both sexes.
- • 3. Chronic periodontitis patients.
- • 4. Probing pocket depth (PPD) 5-7 mm.
- Exclusion Criteria:
- • 1. Subjects having taken antibiotics prior to or during the trial.
- • 2. Patients on medication likely to induce gingival enlargement.
- • 3. Pregnant or lactating women.
- • 4. Smokers.
- • 5. Tobacco chewers.
- • 6. Allergy to curcumin oral gel.
- • 7. Patients with systemic disease.
About University Of Baghdad
The University of Baghdad, a leading academic institution in Iraq, is committed to advancing medical research and improving healthcare outcomes through innovative clinical trials. With a strong emphasis on collaboration and interdisciplinary approaches, the university leverages its extensive network of experts and state-of-the-art facilities to conduct rigorous clinical studies. The institution aims to contribute valuable insights into various health conditions, fostering an environment of scientific inquiry and ethical research practices that ultimately enhance patient care and public health in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Baghdad, , Iraq
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials